ANI Pharmaceuticals ANIP EPS (Basic)
EPS (Basic) at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's eps (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ANI Pharmaceuticals's EPS (basic)?
- ANI Pharmaceuticals (ANIP) reported EPS (basic) of $1.31 in Q1 2026.
- How has ANI Pharmaceuticals's EPS (basic) changed year-over-year?
- ANI Pharmaceuticals's EPS (basic) increased by 87.1% year-over-year, from $0.70 to $1.31.
- What is the long-term trend for ANI Pharmaceuticals's EPS (basic)?
- Over 4 years (2021 to 2025), ANI Pharmaceuticals's EPS (basic) has grown at a 0.7% compound annual growth rate (CAGR), from -$3.40 to $3.50.
- What does EPS (basic) mean?
- Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.